Skip to main content

Personalized Medicine Gets Boost With New Prostate Cancer Finding

In a breakthrough with implications for new therapies, scientists have discovered five groups of prostate cancer, each with different DNA signatures.

Republish
Lead image for this article

In a breakthrough with implications for new therapies, scientists have discovered five groups of prostate cancer, each with different DNA signatures. That discovery means patients may get more customized treatment plans that will try to tackle their subtype. It’s another step toward personalized medicine and a shift from a one-size-fits-all treatment approach. (The Washington Post)




Wait! We need your help.

More than 2 million people read Texas Tribune articles every month, but only 12,000 of those readers also donate to support the news they count on. Not even 1% of readers! If you are one of the 99% of Texas Tribune readers who hasn’t made a donation before in support of independent Texas news, you can change that today. A small donation makes a big impact.

Our Spring Member Drive is an important time to help our newsroom plan for what resources will be available for them to tackle longer investigations and bigger projects later this year. Texas Tribune journalists need the support of readers to write the articles, take the photographs and create the data visualizations that impact Texans and Texas policy.

We have a goal to have 500 readers become Texas Tribune members during our Spring Member Drive. As the Tribune member community grows, the journalism you read here is better protected. Will you make a donation today to show your support of independent Texas news?

DONATE NOW

Information about the authors

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics